Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ICRC-Weyer To Expand Pharmacovigilance Services For Mid-Sized Pharma CompaniesICRC-Weyer GmbH, a Berlin-based clinical contract research organization, is expanding its pharmacovigilance services for small to mid-sized pharmaceutical companies.
By: ICRC-Weyer ‘Our pharmacovigilance services comprise SAE/AE reporting as well as writing Development Safety Update Reports, Periodic Safety Update Reports, Risk Management Plans and more’ says Dr Ulrike Treichel, Head of Pharmacovigilance at ICRC-Weyer. ‘Furthermore, we setup and maintain a validated safety database. We work with a fully validated drug-safety database, VigilanceOne by Pharm App, which enables us to manage trials of all phases and sizes.’ VigilanceOne was developed for – and in cooperation with – the German regulatory authorities Paul-Ehrlich- ‘Our Pharmacovigilance services are especially interesting for small to mid-sized pharmaceutical and biotech companies who generally outsource this type of service.’ About ICRC-Weyer: ICRC-Weyer is an established all-phase contract research organization (CRO) based in Berlin, Germany. The company provides complete turnkey solutions for all stages of the clinical development process, including data management, biostatistics, medical writing and monitoring services. ICRC-Weyer has special expertise in Advanced Therapies, CDISC Data Standards and Medical Monitoring. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|